NCT06395883View on ClinicalTrials.gov

Dynamics in Bone Turnover Markers During and After Short-term Glucocorticoid Treatment in Patients With an Inflammatory Joint Disease

RecruitingOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2028

Conditions
OsteoporosisOsteoporosis, Steroid InducedInflammatory Rheumatism
Interventions
DRUG

Glucocorticoid Effect

Patients with or without glucocorticoid treatment will be observed regarding the level of bone turnover markers (P1NP and CTX1) every 4 weeks til 6 months after the last glucocorticoid dose.

Trial Locations (2)

3024

RECRUITING

Vestre Viken HF, Drammen, Drammen

0319

RECRUITING

Diakonhjemmet hospital, Oslo

All Listed Sponsors
collaborator

Vestre Viken Hospital Trust

OTHER

collaborator

Hormone Laboratory, Aker University Hospital, Oslo, Norway

OTHER

lead

Diakonhjemmet Hospital

OTHER